Safety and efficacy of a novel hyperaemic agent,
intracoronary nicorandil, for invasive
physiological assessments in the cardiac
catheterization laboratory
- Author(s)
- Ho-Jun Jang; Bon-Kwon Koo; Hee-Sun Lee; Jun-Bean Park; Ji-Hyun Kim; Myung-Ki Seo; Han-Mo Yang; Kyung-Woo Park; Chang-Wook Nam; Joon-Hyung Doh; Hyo-Soo Kim
- Keimyung Author(s)
- Nam, Chang Wook
- Department
- Dept. of Internal Medicine (내과학)
- Journal Title
- European Heart Journal
- Issued Date
- 2013
- Volume
- 34
- Issue
- 27
- Abstract
- Aims Maximal hyperaemia is a key element of invasive physiological studies and adenosine is the most commonly used
agent. However, infusion of adenosine requires additional venous access and can cause chest discomfort, bronchial
hyper-reactivity, and atrioventricular conduction block. The aim of this study was to evaluate the feasibility and efficacy
of intracoronary (IC) nicorandil as a novel hyperaemic agent for invasive physiological studies.
Methods
and results
We enrolled 210 patients who underwent fractional flow reserve (FFR) measurement. Hyperaemic efficacy of the
following methods was compared: IC bolus injection of adenosine; intravenous (i.v.) infusion of adenosine
(140 mg/kg/min); and IC bolus of nicorandil (1 and 2 mg). In 70 patients, the index of microcirculatory resistance
was also measured. Hyperaemic efficacy of IC nicorandil 2 mg was non-inferior to that of i.v. adenosine infusion
(FFR: 0.82+0.10 vs. 0.82+0.10; P for non-inferiority , 0.001). There was a strong correlation between FFRs measured
by i.v. adenosine and IC nicorandil (R2 ¼ 0.934). Nicorandil produced fewer changes in blood pressure, heart
rate and PR interval, and less chest pain than adenosine (all P-values , 0.05). Atrioventricular block occurred in 12
patients with IC adenosine, 4 patients with i.v. adenosine and none with IC nicorandil. The index of microcirculatory
resistance was 18.3+8.7 with i.v. adenosine and 17.2+7.6 with IC nicorandil (P ¼ 0.126).
Conclusion This study suggests that IC bolus injection of nicorandil is a simple, safe, and effective way to induce steady-state
hyperaemia for invasive physiological evaluations.
Clinicaltrials.gov number: NCT01331902.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Keywords Fractional flow reserve † Hyperaemia † Nicorandil
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.